No insider purchase over the last 90 days. The latest, by 胡柏藩, was filed 15 Jul 2021.
Zhejiang NHU Company Ltd.: what insiders have been doing
Only a handful of insider records exist for Zhejiang NHU Company Ltd., the last one from 15 July 2021, too few to describe a trend. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Since the insiders bought
- -9.7%Entry CN¥23.64 · Close at T+365 CN¥21.36
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Zhejiang NHU Company Ltd. Buy (bullish), based on 7 analysts. Average price target: CN¥33.34.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,000 shares100.0% of flowA股XSHESZSE:173000004568934400Canonical exit: 13 Oct 2021 (T+90)
1 of 1 declaration
About Zhejiang NHU Company Ltd.
新和成 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the research, development, and production of pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
